Showing results (1571-1580 of 1,621) with videos related to

Sort By:
Pageof 163
The Pharmacogenomics Journal|September 9, 2023
The INGENIOUS trial: Impact of pharmacogenetic testing on adverse events in a pragmatic clinical trialMichael T Eadon, Marc B Rosenman, Pengyue Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2022
Multidecadal declines in particulate mercury and sediment export from Russian rivers in the pan-Arctic basinScott Zolkos, Alexander V Zhulidov, Tatiana Yu Gurtovaya, et al.
JAMA Ophthalmology|April 24, 2020
Short-term Outcomes After Very Low-Dose Intravitreous Bevacizumab for Retinopathy of PrematurityDavid K Wallace, Raymond T Kraker, Sharon F Freedman, et al.
Ophthalmology|July 11, 2006
A symptom survey and quality of life questionnaire for nasolacrimal duct obstruction in childrenJonathan M Holmes, David A Leske, Stephen R Cole, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|February 11, 2014
Relevance weighting of tier 1 endocrine screening endpoints by rank orderChristopher J Borgert, Leah D Stuchal, Ellen M Mihaich, et al.
Cancer Research|October 4, 2018
A Novel Small-Molecule Inhibitor of MRCK Prevents Radiation-Driven Invasion in GlioblastomaJoanna L Birch, Karen Strathdee, Lesley Gilmour, et al.
Haematologica|March 26, 2026
Extracellular vesicles from aged individuals trigger mitochondrial dysfunction in haematopoietic progenitor cellsIsabelle J Grenier-Pleau, Jasleen Kaur, Christopher J Wells, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|April 2, 2011
Role of pharmacokinetics in establishing bioequivalence for orally inhaled drug products: workshop summary reportDennis O'Connor, Wallace P Adams, Mei-Ling Chen, et al.
JCO Oncology Practice|April 15, 2025
Outpatient Management of Bispecific Related Toxicities: An Observational Study of Safety Outcomes and Resource UtilizationJenna R Puttkammer, Jason N Barreto, Chelsee J Jensen, et al.
JAMA Ophthalmology|April 28, 2017
Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity: A Phase 1 Dosing StudyDavid K Wallace, Raymond T Kraker, Sharon F Freedman, et al.
Pageof 163